CKD and Bladder Problems in Children

Penna, Frank J.; Elder, Jack S.

doi:10.1053/j.ackd.2011.08.001

Cited by 37 publications

(31 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,2,8 A systematic monitoring of these indicators is necessary for the appropriate selection of treatment methods and the time of their implementation, optimal for delaying the onset of CKD or slowing its progression. Most important of those prognostic factors include: the age at the time of diagnosis, the serum creatinine level, considerable vesicoureteral reflux, renal dysplasia, and the presence or lack of the bladder dysfunction (Table 1).…”

Section: Ckd Risk Factorsmentioning

confidence: 99%

“…), proteinuria and hypertension, more than 3 episodes of urinary tract infections (UTI) and late surgical intervention. 1,7,9,[17][18][19][20] …”

Section: Voiding Cystourethrographymentioning

confidence: 99%

“…However, it does not prevent renal deterioration and progression to CKD. 1,10,21 All treatment possibilities listed above are illustrated in Fig. 3.…”

Section: Late Diagnosis Of Puvmentioning

confidence: 99%

“…Obstructions in the urinary tract lead to its functional and anatomical changes, and then to the development of CKD. 1,2 Fetal development of the urinary tract is a very complex process, involving a number of genes. 3 The process of nephrogenesis begins between the 3 rd and the 4 th week of gestation, and according to Hennus et al, the onset of histological changes that lead to PUV formation can be observed already in the 4 th week of the fetal life.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Valve bladder syndrome in children: On the trail of the best strategies to prevent chronic kidney disease

Polak−Jonkisz¹,

Rehan²,

Fornalczyk³

et al. 2017

Adv Clin Exp Med

View full text Add to dashboard Cite

Pediatric patients suffering from valve bladder syndrome (VBS) are at risk of developing chronic kidney disease (CKD) and renal failure in later life. Therefore, it is of vital importance to determine the risk factors and the best possible strategies for diagnosis and treatment in patients with VBS that would minimize the risk of developing CKD. In this review we have presented the current knowledge of CKD risk factors in patients with posterior urethal value (PUV). We have also discussed possible recommendations for prenatal diagnostics procedures to be undertaken in patients with PUV, postnatal monitoring and therapeutic strategies that could reduce the risk of developing CKD in this population. Although in most cases there are no clear guidelines for appropriate clinical actions that can be undertaken in patients with PUV to minimize the risk of kidney failure, we have tried to present concise and accurate advice for physicians taking care of patients with PUV.

show abstract

Section: Ckd Risk Factorsmentioning

confidence: 99%

“…), proteinuria and hypertension, more than 3 episodes of urinary tract infections (UTI) and late surgical intervention. 1,7,9,[17][18][19][20] …”

Section: Voiding Cystourethrographymentioning

confidence: 99%

“…However, it does not prevent renal deterioration and progression to CKD. 1,10,21 All treatment possibilities listed above are illustrated in Fig. 3.…”

Section: Late Diagnosis Of Puvmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Valve bladder syndrome in children: On the trail of the best strategies to prevent chronic kidney disease

Polak−Jonkisz¹,

Rehan²,

Fornalczyk³

et al. 2017

Adv Clin Exp Med

View full text Add to dashboard Cite

show abstract

“…Control, during day and night, results from progressive maturation between 1.5 and 5 years of age, with the synchronization of (1) the nycthemeral cycle of urine volume (and its osmolarity), (2) an increase in bladder capacity, and (3) control of detrusor activity. The standard ages for attaining bladder control are as follows [17]: at 1.5 years, the infant knows he is wet; at 2 years, he obtains diurnal control; toilet training between 2 and 4 years of age is normal; and persistent daytime wetting accidents after the age of 5 may indicate a problem.…”

Section: Physiology Of Normal Mictionmentioning

confidence: 99%

Pediatric Bladder Disorders

Bérard

2014

Pediatric Nephrology

View full text Add to dashboard Cite

Botulinum toxin to improve facial expression in a patient with Urofacial (Ochoa) Syndrome

Barbon

Grünherz

Schweizer

et al. 2022

American J of Med Genetics Pt A

View full text Add to dashboard Cite

The Urofacial or Ochoa Syndrome is a very rare congenital disorder that includes vesical bladder dysfunction and a peculiar inverse facial expression, which brings patients to express a sad-crying face while they intend to laugh. Up-to-date treatments have addressed only the urological side of this disease. However, also the impaired facial mimicry has a strong impact on patients' quality of life. We treated a young patient with Botulinum toxin to address this impairment and obtained pleasing results, including a harmonic smile and a very satisfied patient. To the best of our knowledge, this is the first time that the use of Botulinum toxin is reported in literature to address the facial expression component of this disease.

show abstract

CKD and Bladder Problems in Children

Cited by 37 publications

References 54 publications

Valve bladder syndrome in children: On the trail of the best strategies to prevent chronic kidney disease

Valve bladder syndrome in children: On the trail of the best strategies to prevent chronic kidney disease

Pediatric Bladder Disorders

Botulinum toxin to improve facial expression in a patient with Urofacial (Ochoa) Syndrome

Contact Info

Product

Resources

About